Butyrate analogue, isobutyramide, inhibits tumor growth and time to androgen-independent progression in the human prostate LNCaP tumor model
Martin E. Gleave, Naohide Sato, Marianne Sadar, Virginia Yago, Nicholas Bruchovsky, Lorne SullivanVolume:
69
Year:
1998
Language:
english
Pages:
11
DOI:
10.1002/(sici)1097-4644(19980601)69:33.0.co;2-o
File:
PDF, 322 KB
english, 1998